Background: Esmolol is a beta-1 selective blocker that has been shown to reduce postoperative pain. Its antinociceptive effects have not been tested following mastectomy.
Objective: To evaluate the safety, efficacy and antinociception of intra-operative esmolol infusion after mastectomy.